PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-01-08: Reporting owner MacPhee John A; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-01-08: Reporting owner HAUGHEY THOMAS; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-01-08: Reporting owner Campanelli Paul; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-01-08: Reporting owner LEPORE PATRICK G; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-01-08 | MacPhee John A Officer (EVP, Pres.-Strativa) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +99,541 99,541 owned after | $13.06 exercise price | 2009-01-12 | |
| 2009-01-08 | HAUGHEY THOMAS Officer (EVP, Chief Admin Off, Gen Cnsl) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +107,198 107,198 owned after | $13.06 exercise price | 2009-01-12 | |
| 2009-01-08 | Campanelli Paul Officer (EVP, Pres.-Generics) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +99,541 99,541 owned after | $13.06 exercise price | 2009-01-12 | |
| 2009-01-08 | LEPORE PATRICK G Director, Officer (Chairman, Pres and CEO) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +130,934 130,934 owned after | $13.06 exercise price | 2009-01-12 | |
| 2009-01-08 | KENYON LAWRENCE A Other (EVP Finance-Par Pharmaceutical) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +85,758 85,758 owned after | $13.06 exercise price | 2009-01-12 |